Naslov
Enhancement of benzodiazepine binding sites following chronic treatment with flumazenil

Autori
Peričić, Danka ; Jazvinšćak Jembrek, Maja ; Švob Štrac, Dubravka ; Vlainić (Lazić), Josipa ; Rajčan Špoljarić, Ivana

Izvornik
European Journal of Pharmacology (0014-2999) 507 (2005), 1-3; 7-13

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
GABA-A receptor; HEK 293 cells; Flumazenil; Diazepam; GABA (gamma-aminobutyric acid); [3H]flunitrazepam binding
(GABA-A receptor; HEK 293 cell; Flumazenil; Diazepam; GABA (gamma-aminobutyric acid); [3H]flunitrazepam binding)

Sažetak
The aim of this study was to improve our knowledge of the mechanisms leading to adaptive changes in gamma-aminobutyric acid A (GABA-A) receptors following chronic drug treatment. Exposure (48 h) of human embryonic kidney (HEK 293) cells stably expressing recombinant alpha1 beta2 gamma2S GABA-A receptors to the antagonist of benzodiazepine binding sites, flumazenil (5 microM), enhanced the maximum number (Bmax) and the equilibrium dissociation constant (Kd) of [3H]flunitrazepam binding sites. The flumazenil-induced enhancement in Bmax was potentiated by GABA (50 microM), and reduced by the GABA-A receptor antagonist, bicuculline (100 microM). Flumazenil-induced enhancement in Kd was affected by neither of these treatments. GABA (50 microM) enhanced the density of [3H]flunitrazepam binding sites, and this enhancement was greater in the presence of diazepam (1 microM). The results suggest that chronic flumazenil treatment up-regulates in a bicuculline sensitive manner benzodiazepine binding sites at stably expressed GABA-A receptors.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti

POVEZANOST RADA